SLP · Simulations Plus, Inc. · Executive Compensation
Market Cap
$372.54M
Shares
20.22M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $1,096,572 |
| Daniel Szot | Former Chief Revenue Officer | $559,945 |
| Will Frederick | Executive Vice President & Chief Financial Officer | $534,653 |
| John DiBella | Chief Revenue Officer | $488,972 |
| Steven Chang | Global Head of Strategic Alliances | $482,276 |
| Jill Fiedler-Kelly | President Services Solutions | $465,078 |
| Josh Fohey | Chief Operating Officer | $358,273 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $1,657,620 |
| Will Frederick | Chief Financial Officer & Chief Operating Officer | $1,007,280 |
| Daniel Szot | Chief Revenue Officer | $895,066 |
| Dr. Brett Howell | Former Business Unit President, QSP Solutions | $856,831 |
| John DiBella | Business Unit President, PBPK and CHEM Solutions | $661,624 |
| Steven Chang | Business Unit President, QSP Solutions | $656,414 |
| Jill Fiedler-Kelly | President Services Solutions | $609,423 |
| Josh Fohey | Chief Operating Officer | — |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $1,942,005 |
| Will Frederick | Chief Financial Officer & Chief Operating Officer | $880,897 |
| John DiBella | Business Unit President, PBPK and CHEM Solutions | $728,135 |
| Jill Fiedler-Kelly | Business Unit President | $722,102 |
| Dr. Brett Howell | Former Business Unit President, QSP Solutions | $649,999 |
| Steven Chang | Business Unit President, QSP Solutions | $238,585 |
| Daniel Szot | Chief Revenue Officer | — |
| Josh Fohey | Chief Operating Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $1,342,852 |
| John DiBella | Business Unit President, PBPK and CHEM Solutions | $536,764 |
| Will Frederick | Chief Financial Officer & Chief Operating Officer | $504,273 |
| Jill Fiedler-Kelly | Business Unit President | $408,655 |
| Dr. Brett Howell | Former Business Unit President, QSP Solutions | $408,134 |
| Daniel Szot | Chief Revenue Officer | — |
| Steven Chang | Business Unit President, QSP Solutions | — |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $1,072,271 |
| Will Frederick | Chief Financial Officer | $753,032 |
| John DiBella | Business Unit President | $524,633 |
| Dr. Brett Howell | Business Unit President | $475,542 |
| Jill Fiedler-Kelly | Business Unit President | $464,367 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $739,400 |
| John DiBella | President, Simulations Plus Division | $346,536 |
| Jill Fiedler-Kelly | President, Cognigen Division | $312,234 |
| John Kneisel | Chief Financial Officer | $305,685 |
| Dr. Brett Howell | President, DILIsym Division | $274,398 |
| Will Frederick | Chief Financial Officer | — |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Shawn O'Connor | Chief Executive Officer | $425,000 |
| John DiBella | President Lancaster Division | $325,860 |
| John Kneisel | Chief Financial Officer | $275,959 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Dr. John K. Paglia | Director | Appointed | 2026-02-18 |
| Sharlene Evans | Director | Appointed | 2026-02-18 |
| Dr. Walter S. Woltosz | Director | Appointed | 2026-02-18 |
| Dr. Daniel Weiner | Director | Appointed | 2026-02-18 |
| Viera Lukacova | Chief Scientific Officer | Appointed | 2025-12-08 |
| Josh Fohey | Chief Operating Officer | Appointed | 2025-12-08 |
| Erik Guffrey | Co-Chief Product & Technology Officer | Appointed | 2025-12-08 |
| Murry Alper | Global Head of Medical Communications | Appointed | 2025-06-02 |
| Steven Chang | Global Head of Strategic Alliances | Appointed | 2025-06-02 |
| Jenna Rouse | Global Head of Clinical Operations | Appointed | 2025-06-02 |
| Erik Guffrey | Co-Chief Product and Technology Officer | Appointed | 2025-06-02 |
| Jill Fiedler-Kelly | Interim President, Services Solutions | Appointed | 2025-06-02 |
| Jonathan Chauvin | Co-Chief Product and Technology Officer | Appointed | 2025-06-02 |
| Josh Fohey | Chief Operating Officer | Appointed | 2025-06-02 |
| Will Frederick | Executive Vice President and Chief Financial Officer | Appointed | 2025-06-02 |
| John DiBella | Chief Revenue Officer | Appointed | 2025-06-02 |
| Steven Chang | President, Quantitative Systems Pharmacology | Appointed | 2024-08-23 |
| Brett Howell | President, Quantitative Systems Pharmacology | Resigned | 2024-08-23 |